Emirates Drug Establishment Approves Tapinarof Cream 1%, A New Treatment For Plaque Psoriasis In Adults And Atopic Dermatitis ...

In the second half of his Maui Derm recap, George Martin, MD, founder and program director of the meeting, highlights new ...

A Virginia family of four has filed a federal lawsuit seeking 200,000 dolars in damages from KLM Royal Dutch Airlines and ...

Dompé, a leading biopharmaceutical company with operations in Italy and the U.S., announced the first patients have been enrolled in a Phase 3 study of Isocyclosporin for the treatment of atopic ...

Exclusive: Ophthalmologist Romulo Albuquerque, his wife and their two kids say the bites across their necks, torsos, legs, ...

A Virginia family flying KLM Royal Dutch Airlines from the United States to Europe claims their pricey business-class seats ...

Galderma (SIX: GALD), the pure-play dermatology category leader, today released new clinical data confirming nemolizumab's rapid onset of action on itch and sleep, with significant improvements ...

Atopic dermatitis’ (AD) deeper complexities were exposed in 2025. Once seen mainly as a visible skin condition, AD is now widely recognized as a long-lasting inflammatory disease that affects sleep, ...

Coherus Oncology, Inc. (NASDAQ: CHRS) today announced compelling six-year overall survival (OS) follow-up results from the Phase 3 JUPITER-02 trial evaluating LOQTORZI® (toripalimab-tpzi) plus ...

Approval based on global Phase 3 program in children demonstrating Dupixent significantly reduced exacerbations (by 54% to 65%) and improved lung ...

Discusses Year-End Late-Stage Pipeline Review With Focus on Clinical and Regulatory Developments December 16, 2025 11:15 AM ...

Approval based on global Phase 3 program in children demonstrating Dupixent significantly reduced exacerbations (by 54% to 65%) and improved lung function (by 4.68% to 5.32%) compared to placebo Dupix ...